PROTECT
Phase 2 Completed
106 enrolled
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Phase 1/2 Completed
214 enrolled
ARION
Phase 2 Completed
112 enrolled
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Phase 2 Completed
37 enrolled 11 charts
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Phase 3 Completed
545 enrolled 24 charts
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Phase 1/2 Completed
73 enrolled 18 charts
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Phase 2 Completed
257 enrolled 13 charts
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
Phase 2 Completed
37 enrolled 8 charts
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
Phase 3 Completed
377 enrolled
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase 2 Completed
20 enrolled 10 charts
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
Phase 1/2 Completed
59 enrolled 8 charts
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Completed
245 enrolled 15 charts
MATEO
Phase 2 Completed
242 enrolled
MEGA
Phase 2 Completed
162 enrolled
FOLFIRINOX
Phase 2 Completed
67 enrolled 14 charts
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
Phase 2 Completed
39 enrolled 11 charts
PALAESTRA
Phase 2 Completed
29 enrolled
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
Phase 2 Completed
64 enrolled 11 charts
SOX
Phase 1 Completed
40 enrolled
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Phase 2 Completed
213 enrolled 17 charts
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Phase 1 Completed
66 enrolled
Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
Phase 2 Completed
39 enrolled 10 charts
VEOX
Phase 1 Completed
12 enrolled
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 1 Completed
9 enrolled
Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery
Phase 2 Completed
29 enrolled 12 charts
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Phase 2 Completed
48 enrolled
Chronos
Phase 2 Completed
23 enrolled
CCRT for Esophageal Cancer.
Phase 2 Completed
34 enrolled
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Phase 2 Completed
26 enrolled 24 charts
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
Phase 2/3 Completed
266 enrolled
POXX
Phase 1/2 Completed
29 enrolled 10 charts
XAGastric
Phase 2 Completed
60 enrolled 9 charts
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
Phase 2 Completed
126 enrolled 8 charts
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Phase 2 Completed
168 enrolled 16 charts
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
Phase 2 Completed
41 enrolled 8 charts
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
Phase 2 Completed
98 enrolled 9 charts
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
Phase 1 Completed
36 enrolled
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
Phase 2 Completed
35 enrolled
Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Phase 2 Completed
41 enrolled